Brief: Charmacy Pharmaceutical Announces Proposed Appointment Of Zhang Hanzi As Executive Director
17/06/2022 16:15
June 17 (Reuters) - Charmacy Pharmaceutical Co Ltd
2289.HK :
* PROPOSED APPOINTMENT OF ZHANG HANZI AS EXECUTIVE DIRECTOR
Source text for Eikon: ID:nHKS2mFYwh
Further company coverage: 2289.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charmacy Pharmaceutical
See all newsBrief: Charmacy Pharmaceutical Sees Decrease In Net Profit Attributable By 45% For Year
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17